Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Ho R

11 indexed publications match this author name.

ORCID: 0000-0001-9629-4493
OpenAlex: https://openalex.org/A5062759333

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Review Article 6 Mechanism of Action 4 Systematic Review 4 Depression 4 Receptor Pharmacology 3 Safety 3 Treatment-Resistant Depression 3 In Vitro Study 2 Pharmacology 2 Biomarkers 2 Randomized Controlled Trial 2 Anxiety 2

Journals

Journal of affective disorders 2 CNS drugs 2 RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia 1 Pharmacopsychiatry 1 Instituto Politécnico do Porto 1 Drug and Alcohol Dependence 1 Science advances 1 Expert review of neurotherapeutics 1

Publication history

Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening StudyRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01 Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.Pharmacopsychiatry · 2026-03-01 Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico EvidenceInstituto Politécnico do Porto · 2026-02-25 High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-07-01 Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.Journal of affective disorders · 2024-06-15 A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.Journal of affective disorders · 2024-04-01 A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.CNS drugs · 2022-10-01 Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.CNS drugs · 2022-01-01 Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Science advances · 2021-11-19 The emerging role of psilocybin and MDMA in the treatment of mental illness.Expert review of neurotherapeutics · 2020-12-01 Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar ratsBehavioural Pharmacology · 2018-09-01

Author directory